Literature DB >> 2114989

The effect of pharmacological modification of gastric emptying and mouth-to-caecum transit time on the absorption of sugar probe marker molecules of intestinal permeability in normal man.

A L Brunetto1, A D Pearson, R Gibson, D N Bateman, M U Rashid, M F Laker.   

Abstract

The present study examined the hypothesis that altered motility of the gastrointestinal tract affects absorption of probe markers of intestinal permeability. Seven healthy subjects, aged 32-44 years, received saline, 600 micrograms atropine or 10 mg metoclopramide in randomized order at weekly intervals. After 10 min they ingested a test solution containing 5 g lactulose, 5 g mannitol and 2 g 3-O-methyl glucose in 100 ml tap water. The molarity of the solution was 542 mmol l-1 and the dose administered was 80 ml m-2 body surface area. Gastric emptying was measured by ultrasound, mouth-to-caecum transit time by breath hydrogen analysis and sugar concentrations by gas-liquid chromatography. Gastric emptying half-times (min) were [mean (95% confidence intervals)] 14.9 (11:4-18.5) after saline, 22 (18.7-25.2) after atropine and 10.3 (7.0-12.6) after metoclopramide (P less than 0.002). Transit times (min) were 68.9 (52-85.2) after saline, 143 (126-159) after atropine and 38 (21.2-54.5) after metoclopramide; P less than 0.0001. Analysis of plasma levels of mannitol and 3-O-methyl glucose showed a significant within-subject effect of drug with time (P less than 0.03). Urinary excretion of mannitol in the first 5 h after ingestion of the test solution was 1256 (974-1620) mg after saline, 1560 (1210-2013) mg after atropine and 955 (740-1232) mg after metoclopramide (P less than 0.03). There were no significant differences in lactulose and 3-O-methyl glucose urinary excretion between drug treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114989     DOI: 10.1111/j.1365-2362.1990.tb01856.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  8 in total

1.  The digestive adaptation of flying vertebrates: high intestinal paracellular absorption compensates for smaller guts.

Authors:  Enrique Caviedes-Vidal; Todd J McWhorter; Shana R Lavin; Juan G Chediack; Christopher R Tracy; William H Karasov
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

2.  Challenging boundaries: an enhanced recovery programme for radical cystectomy.

Authors:  S Mukhtar; B E Ayres; R Issa; M J Swinn; M J A Perry
Journal:  Ann R Coll Surg Engl       Date:  2013-04       Impact factor: 1.891

3.  The influence of gastrointestinal transit on drug absorption in healthy volunteers.

Authors:  S A Riley; F Sutcliffe; M Kim; M Kapas; M Rowland; L A Turnberg
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

4.  Gastrointestinal function in chronic radiation enteritis--effects of loperamide-N-oxide.

Authors:  E K Yeoh; M Horowitz; A Russo; T Muecke; T Robb; B E Chatterton
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 5.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

6.  Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.

Authors:  M Magnusson; K E Magnusson; T Sundqvist; T Denneberg
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

7.  Effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients.

Authors:  C A Knupp; R L Milbrath; R H Barbhaiya
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Glucose absorption and gastric emptying in critical illness.

Authors:  Marianne J Chapman; Robert J L Fraser; Geoffrey Matthews; Antonietta Russo; Max Bellon; Laura K Besanko; Karen L Jones; Ross Butler; Barry Chatterton; Michael Horowitz
Journal:  Crit Care       Date:  2009-08-27       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.